HUBS - HubSpot, Inc. | BullzEye View

HUBS

$218.62 +12.18 (+5.90%) Last updated: Apr 16, 2026 00:59

52-Week Range

$218.62

$187.45 $218.62 $682.57

Fundamentals Overview

HubSpot, Inc. is near the low of its 52-week range with premium valuation, showing strong upward momentum today.

Valuation premium

P/E 250.2 PEG 0.28 P/B 5.55 P/S 3.68

Intrinsic value (DCF)

-62.9% downside vs price

Profitability

Net margin 1.5%

Risk (Beta)

1.44 — higher vol

Earnings & growth

EPS $0.87 Rev +4.5% Profit +229.1% vs prior qtr

BullzEye Analysis

Our composite tilts Sell on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Sell — 93% confidence Risk: High Volatility — Beta 1.44. Consider smaller position size due to higher beta.

Pressures (Sell):

DCF 62.9% downside vs price · Sentiment weakening (1 downgrade) · 3M vs S&P 500: -42.5% · 3M vs Technology sector: -44.2% · Beta 1.44 (elevated)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$11.53B

P/E (TTM)

250.22

EPS (TTM)

$0.87

Dividend Yield

N/A

52-Week Range

$187.45 - $682.57

Volume vs Avg

N/A

Beta

1.44

About

HubSpot, Inc. provides a cloud-based customer relationship management (CRM) platform for businesses in the Americas, Europe, and the Asia Pacific. The company's CRM platform includes marketing, sales, service, and content management systems, as well as integrated applications, such as search engine optimization, blogging, website content management, messaging, chatbots, social media, marketing automation, email, predictive lead scoring, sales productivity, knowledge base, commerce, conversation ...

Sector: Technology

Headquarters: US

Employees: 8,574

IPO Date: Oct 2014

Website: www.hubspot.com

Beta: 1.44 (More volatile than market)

Ratings & Grades at a Glance

Overall rating: C+. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 14, Neutral: 1, Outperform: 5, Overweight: 10.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $81.12; current price is $218.62. That’s a -62.9% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric	Value
Valuation
P/E (TTM)	250.22
DCF value (model)	$81.12 (-62.9% vs price)
PEG (TTM)	0.28
P/B (TTM)	5.55
P/S (TTM)	3.68
P/FCF (TTM)	17.02
Liquidity & enterprise
Current Ratio (TTM)	1.52
Quick Ratio (TTM)	1.52
Cash Ratio (TTM)	0.6
Profitability
ROE (TTM)	N/A
ROA (TTM)	N/A
Revenue growth (YoY)	N/A
Net margin (TTM)	1.47%
Gross margin (TTM)	83.76%
Operating margin (TTM)	0.25%
Debt to equity (TTM)	N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for HUBS.

Analyst Sentiment at a Glance

C+ Sentiment Weakening

Buy 14Neutral 1Outperform 5Overweight 10

0 upgrades, 1 downgrade

Price Target Consensus

Current $218.62

Median $325.00

Consensus $368.00

Low consensus $260.00

High consensus $577.00

Stock Grades (Institutions)

Institution	Action	Previous Grade	New Grade	Date
Stifel	maintain	Buy	Buy	2026-04-02
Cantor Fitzgerald	maintain	Overweight	Overweight	2026-03-03
Barclays	maintain	Overweight	Overweight	2026-02-13
Citigroup	maintain	Buy	Buy	2026-02-13
Macquarie	maintain	Outperform	Outperform	2026-02-12
BMO Capital	maintain	Outperform	Outperform	2026-02-12
UBS	maintain	Buy	Buy	2026-02-12
Jefferies	maintain	Buy	Buy	2026-02-12
Goldman Sachs	maintain	Buy	Buy	2026-02-12
JP Morgan	maintain	Overweight	Overweight	2026-02-12
Cantor Fitzgerald	maintain	Overweight	Overweight	2026-02-12
Truist Securities	maintain	Buy	Buy	2026-02-12
RBC Capital	maintain	Outperform	Outperform	2026-02-12
Piper Sandler	maintain	Overweight	Overweight	2026-02-12
Keybanc	maintain	Overweight	Overweight	2026-02-12
Needham	maintain	Buy	Buy	2026-02-12
Wells Fargo	maintain	Overweight	Overweight	2026-02-12
Mizuho	maintain	Outperform	Outperform	2026-02-12
BTIG	maintain	Buy	Buy	2026-02-12
Oppenheimer	maintain	Outperform	Outperform	2026-02-04
Citigroup	maintain	Buy	Buy	2026-02-04
Piper Sandler	maintain	Overweight	Overweight	2026-02-03
UBS	maintain	Buy	Buy	2026-01-28
Goldman Sachs	maintain	Buy	Buy	2026-01-28
Stifel	maintain	Buy	Buy	2026-01-23
Morgan Stanley	maintain	Overweight	Overweight	2026-01-15
Barclays	maintain	Overweight	Overweight	2026-01-12
Argus Research	maintain	Buy	Buy	2025-11-20
Rothschild & Co	downgrade	Buy	Neutral	2025-11-10
Goldman Sachs	maintain	Buy	Buy	2025-11-07